FIELD: medicine.
SUBSTANCE: invention relates to field of medicine, in particular, to ophthalmology. Therapeutic medication for treatment of corneal-conjunctival disturbance contains eprosartan or its salt as active ingredient. Medication is made in dosed form, which is applied by introduction to patient during treatment in form of eye drops or ophthalmic ointment.
EFFECT: invention ensures treatment of such disturbances as dry eye syndrome, ulcer of cornea, keratitis, conjunctivitis, punctuate superficial keratitis, disturbances of corneal epithelium, dry keratoconjunctivitis, upper limbic keratoconjunctivitis or filamentary keratitis.
9 cl, 1 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
PREVENTIVE OR THERAPEUTIC AGENT FOR TREATMENT OF KERATOCONJUCTIVAL DISORDERS | 2006 |
|
RU2406499C2 |
METHOD FOR TREATMENT OF INFLAMMATORY EYE DISEASES ASSOCIATED WITH AUTOIMMUNE PATHOLOGIES | 2016 |
|
RU2618167C1 |
THERAPEUTIC MEDICATION AGAINST KERATOCONJUNCTIVAL DISTURBANCE | 2006 |
|
RU2420280C2 |
THERAPEUTIC AGENT FOR KERATOCONJUNCTIVE DISORDERS | 2013 |
|
RU2659203C2 |
GEL-LIKE ARTIFICIAL TEARS WITH ANTISEPTIC AND REPARATIVE ACTION | 2018 |
|
RU2679319C1 |
OPHTHALMOLOGICAL COMPOSITIONS | 2017 |
|
RU2756758C2 |
EYE GEL DROPS FOR TREATMENT OF INFLAMMATORY, VIRUS, BACTERIAL, ALLERGIC, METABOLIC, TRAUMATIC DISEASES | 2017 |
|
RU2688687C1 |
PHARMACEUTICAL COMPOSITION IN FORM OF GEL FOR TREATING METABOLIC INVOLVEMENTS OF OCULAR TISSUES | 2014 |
|
RU2575558C1 |
EYE GEL DROPS FOR TREATING ACUTE AND CHRONIC INFLAMMATORY EYE DISEASES CAUSED BY VIRAL, BACTERIAL, ALLERGIC, METABOLIC OR TRAUMATIC FACTORS | 2018 |
|
RU2692087C1 |
METHOD FOR TREATING THE CASES OF DRY EYE SYNDROME | 2005 |
|
RU2290923C2 |
Authors
Dates
2011-07-10—Published
2006-12-06—Filed